trimethoprim has been researched along with Cholera Infantum in 28 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether the trimethoprim component can be the cause of an anaphylactic reaction." | 7.70 | Anaphylactic reactions associated with trimethoprim. ( Bijl, AM; Stricker, BH; Van der Klauw, MM; Van Vliet, AC, 1998) |
| "Although evidence suggests that erythromycin at 50 mg/kg per day for 14 days results in higher numbers of cure than does azithromycin, compliance and risk of pyloric stenosis related to their use for other infections in neonates will factor into treatment recommendations." | 4.98 | Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis. ( Broutet, N; Lincetto, O; Santesso, N; Schünemann, H; Wi, T; Zikic, A, 2018) |
| "To determine whether the trimethoprim component can be the cause of an anaphylactic reaction." | 3.70 | Anaphylactic reactions associated with trimethoprim. ( Bijl, AM; Stricker, BH; Van der Klauw, MM; Van Vliet, AC, 1998) |
| "Norfloxacin has been compared to placebo (136 patients), sulfamethoxazole plus trimethoprim (SXT, 72 patients) and oral vancomycin plus colistin (V/C, 61 patients) for the prevention of alimentary tract-associated infections during and after induction chemotherapy." | 2.66 | The tolerability profile of prophylactic norfloxacin in neutropenic patients. ( Corrado, ML; Hesney, M; Struble, WE, 1988) |
| "Treatment with trimethoprim reduced significantly the periurethral colonization of Escherichia coli." | 2.65 | Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine. ( Brumfitt, W; Cooper, J; Gargan, RA; Hamilton-Miller, JM; Smith, GW, 1983) |
| "The efficacy of a new low dosage trimethoprim-sulfamoxole combination (Supristol) was tested in a joint therapeutic study in 6 medical clinics or departments and in a general practice." | 2.64 | [New sulfonamide-trimethoprim combination, Supristol. Results of a joint therapeutic trial (author's transl)]. ( Frank, H; Jurisch, H; Kabelitz, HJ; Staudacher, H; Stoll, S; Summa, JD; Wagner, A, 1977) |
| "The cause of AIDS is unknown." | 1.27 | Infectious complications of the acquired immune deficiency syndrome. ( Armstrong, D; Gold, JW, 1984) |
| "Norfloxacin was least active against Clostridium difficile (90% minimal inhibitory concentration, 128 micrograms/ml)." | 1.27 | In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. ( Gadebusch, HH; Shungu, DL; Weinberg, E, 1983) |
| " A significant dose-response effect was found with both amoxicillin and trimethoprim/sulfamethoxazole." | 1.27 | Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients. ( Contardi, R; Flegel, KM; Hutchinson, TA; Kramer, MS; Leduc, DG; Naimark, L, 1985) |
| " Long-term administration does not per se seem to represent an additional hazard provided the dose is the correct one and the hematologic monitoring of the patient is performed regularly." | 1.25 | Adverse reactions to trimethoprim-sulfamethoxazole, with particular reference to long-term therapy. ( Bernstein, LS, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (78.57) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Mokraoui, NR | 1 |
| Ganim, R | 1 |
| Paez, A | 1 |
| Zikic, A | 1 |
| Schünemann, H | 1 |
| Wi, T | 1 |
| Lincetto, O | 1 |
| Broutet, N | 1 |
| Santesso, N | 1 |
| Iaccheri, B | 1 |
| Fiore, T | 1 |
| Papadaki, T | 1 |
| Androudi, S | 1 |
| Janjua, S | 1 |
| Bhaila, I | 1 |
| Stephen Foster, C | 1 |
| Sheerin, NS | 1 |
| Bhatacharia, KF | 1 |
| Webb, MC | 1 |
| Gold, JW | 1 |
| Armstrong, D | 1 |
| Shungu, DL | 1 |
| Weinberg, E | 1 |
| Gadebusch, HH | 1 |
| Brumfitt, W | 1 |
| Hamilton-Miller, JM | 1 |
| Gargan, RA | 1 |
| Cooper, J | 1 |
| Smith, GW | 1 |
| Burt, RA | 1 |
| Conforti, A | 1 |
| Gugliemo, L | 1 |
| Naldi, L | 1 |
| Cocci, A | 1 |
| Venegoni, M | 1 |
| Leone, R | 1 |
| Bijl, AM | 1 |
| Van der Klauw, MM | 1 |
| Van Vliet, AC | 1 |
| Stricker, BH | 1 |
| Bernstein, LS | 1 |
| Kasanen, A | 1 |
| Anttila, M | 1 |
| Elfving, R | 1 |
| Kahela, P | 1 |
| Saarimaa, H | 1 |
| Sundquist, H | 1 |
| Tikkanen, R | 1 |
| Toivanen, P | 1 |
| Steidl, B | 1 |
| Frank, H | 1 |
| Jurisch, H | 1 |
| Kabelitz, HJ | 1 |
| Staudacher, H | 1 |
| Stoll, S | 1 |
| Summa, JD | 1 |
| Wagner, A | 1 |
| Etzel, M | 1 |
| Lehmann, H | 1 |
| Steiner, H | 1 |
| Wesenberg, W | 1 |
| Neu, HC | 1 |
| Corrado, ML | 1 |
| Struble, WE | 1 |
| Hesney, M | 1 |
| Kramer, MS | 1 |
| Hutchinson, TA | 1 |
| Naimark, L | 1 |
| Contardi, R | 1 |
| Flegel, KM | 1 |
| Leduc, DG | 1 |
| Salter, AJ | 1 |
| Frisch, JM | 1 |
| Markoff, N | 1 |
| Horka, M | 1 |
| Wahnbeck, D | 1 |
| Hohenauer, L | 1 |
| Schmid, F | 1 |
| Haus, E | 1 |
| Schreiber, A | 1 |
| Tauchnitz, C | 1 |
| Hitchings, GH | 1 |
| Melén, B | 1 |
| Orsten, PA | 1 |
| Garrod, LP | 1 |
| Wegmüller, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing Due to New Episodes of Urinary Tract Infections (UTI) in Elderly Women With Recurrent UTI - a Triple- Blinded, Randomized Placebo-controlled Phase IV Study[NCT04077580] | Phase 4 | 400 participants (Anticipated) | Interventional | 2019-11-01 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for trimethoprim and Cholera Infantum
| Article | Year |
|---|---|
Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Bias; Chlamydia Infections; Chlamydia trachomatis; Conjunctivit | 2018 |
Folate antagonists as antibacterial and antiprotozoal agents.
Topics: Anti-Bacterial Agents; Antimalarials; Antiprotozoal Agents; Escherichia coli; Folic Acid Antagonists | 1971 |
7 trials available for trimethoprim and Cholera Infantum
| Article | Year |
|---|---|
Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine.
Topics: Administration, Topical; Adult; Clinical Trials as Topic; Drug Eruptions; Drug Resistance, Microbial | 1983 |
Review of adverse reactions associated with cinoxacin and other drugs used to treat urinary tract infections.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents, Urinary; Central Nervous System Diseases; Cinoxacin | 1984 |
Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Clinical Trials as Topic; Dose-Respons | 1978 |
[New sulfonamide-trimethoprim combination, Supristol. Results of a joint therapeutic trial (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Blood Sedimentation; Child; Chronic Di | 1977 |
[Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123)/Fourth communication: Clinical results with CN 3123 in infections of the gastrointestinal tract, the skin and gynecological adnexes (author's transl)].
Topics: Adolescent; Adult; Aged; Biliary Tract Diseases; Child; Clinical Trials as Topic; Drug Combinations; | 1976 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestina | 1988 |
[Trimethoprim-sulfamethosazale (Bactrim) in gastroenterology (author's transl)].
Topics: Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Gastrointestinal Diseases; Humans; Sul | 1974 |
19 other studies available for trimethoprim and Cholera Infantum
| Article | Year |
|---|---|
Chest wall abscess and costochondritis due to Salmonella enterica serotype Choleraesuis: a case report.
Topics: Abscess; Aged; Bacteremia; Female; Gastrointestinal Diseases; Humans; Salmonella; Salmonella enteric | 2023 |
Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Topics: Adolescent; Adult; Atovaquone; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse | 2008 |
Positron emission tomography in a patient with renal malacoplakia.
Topics: Abdominal Pain; Ascorbic Acid; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Gastrointest | 2003 |
Infectious complications of the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Bacterial Infections; Cytomegalovirus Infections; Drug Co | 1984 |
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Digestive System; Drug Combinations; Drug Res | 1983 |
Brodimoprim: adverse drug reactions from spontaneous reporting.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Infective Agents; Central Nervous System Diseases; Gas | 1997 |
Anaphylactic reactions associated with trimethoprim.
Topics: Adult; Aged; Anaphylaxis; Anti-Infective Agents, Urinary; Antibodies, Anti-Idiotypic; Female; Gastro | 1998 |
Adverse reactions to trimethoprim-sulfamethoxazole, with particular reference to long-term therapy.
Topics: Adult; Aged; Bacterial Infections; Blood Cell Count; Blood Cells; Blood Platelets; Child; Drug Combi | 1975 |
[A clinical-therapeutic study on high dose lidaprim tablets in severe bacterial infections].
Topics: Adult; Albuminuria; Bacterial Infections; Drug Combinations; Drug Evaluation; Drug Resistance, Micro | 1979 |
Newer antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephapirin; Cephradine; Clindamycin; | 1975 |
Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients.
Topics: Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Cloxacillin; Diar | 1985 |
The toxicity profile of trimethoprim-sulphamethoxazole after four years of widespread use.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Animals; Anti-Infective Agents; Child; Child, Presch | 1973 |
Clinical experience with adverse reactions to trimethoprim-sulfamethoxazole.
Topics: Aged; Agranulocytosis; Anemia, Aplastic; Anemia, Macrocytic; Child; Depression; Drug Combinations; D | 1973 |
[Clinical experiences with the combination of trimethoprim and sulfamethoxazol (Bactrim) in pediatric patients].
Topics: Anti-Infective Agents; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Exanthema; | 1972 |
[Antibiotic therapy--conclusion. 5. Sulfonamides, trimethoprim].
Topics: Agranulocytosis; Bacterial Infections; Colitis; Cyanosis; Gastrointestinal Diseases; Humans; Psychos | 1973 |
[Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bacteriuria; Bronchiectasis; B | 1970 |
[Results of trimethoprim and sulfamethoxazole therapy in chronic urinary tract infections].
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Exa | 1971 |
[Therapy with trimethoprim-sulfonamide. Clinical results].
Topics: Anti-Infective Agents; Bacterial Infections; Folic Acid Antagonists; Gastrointestinal Diseases; Huma | 1971 |
[Treatment of chronically recurring urinary tract infection with trimethoprim sulfamethoxazole (Eusaprim)].
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Female; Folic Acid Antagonists; Gastrointestina | 1970 |